Mylonib 5mg tablet

Mylonib 5mg is an oral tablet containing Ruxolitinib phosphate,

used to treat intermediate or Mylonib 5mg price high-risk myelofibrosis and polycythemia vera by inhibiting Janus Mylonib 5mg online kinase (JAK) enzymes.

It helps manage symptoms such as spleen size Mylonib 5mg tablet online  enlargement.

It is a prescription-only medication, often Mylonib 5mg in pakistan requiring dosage adjustments based on platelet counts.

Product Brand

Mylonib Tablet 5mg  Active Ingredient.

Ruxolitinib (phosphate form)Drug Classification: JAK Inhibitor/Antineoplastic Agent Manufactured By: Pharmasol Other Available Doses: Also available in 15 mg and 20 mg doses provided by the same manufacturer.

Uses of Mylonib The indications for using Mylonib tablets include: Myelofibrosis (MF): Treatment for intermediate or high-risk myelofibrosis in adults, including both primary MF, post-polycy themia vera MF,

and post-essential thrombo cythemia MF.Poly cythemia Vera (PV): Treatment for adult individuals unresponsive or intolerant of Hydroxyurea. Graft Versus Host Disease (GVHD): Management of steroid-refractory acute GVHD

as well as chronic GVHD in adults and children aged 12 years and above.

Recommended Dosing and Administration Dosage and Administration: The dosage to be administered is wholly determined by the treating oncologist/ hematologist depending on baseline platelet count and complete blood count (CBC).Monitoring: It is mandatory to conduct a complete blood cell count and platelet count before starting medication and regularly for up to two to four weeks during stabilization.